Quantitative crystallinity determination for E1010, a novel carbapenem antibiotic, using differential scanning...

Area of Science:

• Pharmaceutical Sciences
• Solid-State Chemistry
• Analytical Chemistry

Background:

• The carbapenem antibiotic E1010 requires precise characterization of its bulk drug properties.
• Understanding the crystalline structure and solid-state behavior is crucial for drug quality and stability.

Purpose of the Study:

• To develop a quantitative method for assessing the crystallinity of E1010 bulk drug.
• To establish a reliable analytical technique for quality control and stability prediction.

Main Methods:

• Utilized X-ray analyses, thermal analyses (including differential scanning calorimetry - DSC), and hygroscopicity measurements.
• Investigated the relationship between DSC enthalpy change and the crystalline form ratio of E1010.
• Analyzed binary physical mixtures of crystalline trihydrate and amorphous E1010.

Main Results:

• E1010 bulk drug exists as a crystalline trihydrate with a unique layered structure.
• A strong correlation was observed between DSC enthalpy change and the crystalline content.
• Enthalpy change positively correlated with the solid-state chemical stability of E1010.

Conclusions:

• Differential scanning calorimetry (DSC) provides a viable quantitative method for E1010 crystallinity analysis.
• This DSC-based method can be applied for quality control, detecting batch variability.
• The method aids in estimating the chemical stability of E1010, particularly for partially amorphous samples.